News

Published on 24 Feb 2022 on Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings...


Article preview image

Here's a roundup of top developments in the biotech space over the last 24 hours:

Adagio Therapeutics, Inc., (NASDAQ: ADGI) announced that its board has appointed David Hering as interim chief executive officer, effective immediately. Hering's appointment came following the resignation of Tillman Gerngross as CEO. The interim CEO will retain his role as chief operating officer.

NASDAQ.VIR price evolution
NASDAQ.MMSI price evolution
NASDAQ.MGNX price evolution
NASDAQ.GTHX price evolution
NASDAQ.LMAT price evolution
NASDAQ.IOVA price evolution
NASDAQ.LUNG price evolution
NYSE.EBS price evolution
NASDAQ.DTIL price evolution
NASDAQ.EDIT price evolution
NASDAQ.PCRX price evolution
NASDAQ.NTRA price evolution
NASDAQ.PLSE price evolution
NASDAQ.FOLD price evolution
NASDAQ.OPK price evolution
NASDAQ.SGMO price evolution
NYSE.NVTA price evolution
NASDAQ.BMRN price evolution
NASDAQ.ICUI price evolution
NASDAQ.ABCL price evolution
NASDAQ.CDNA price evolution
NASDAQ.CDXS price evolution
NASDAQ.AGIO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M

Shares of KemPharm, Inc. KMPH were up 7.1% on Monday after the company announced on May 15 that i...

Zacks via Yahoo Finance 17 May 2022

KemPharm Acquires Battered Orphazyme's Arimoclomol Program For $13M

KemPharm Inc (NASDAQ: KMPH) has agreed to acquire Orphazyme A/S's (in reconstruction) (OTC: ORPHY...

Benzinga via Yahoo Finance 16 May 2022

Orphazyme Withdraws European Application For Arimoclomol, Initiates Delisting Of Its ADSs

Orphazyme A/S (NASDAQ: ORPH) has decided to withdraw its European Marketing Application for arimo...

Benzinga via Yahoo Finance 22 Mar 2022

Dear ORPH Stock Fans, Mark Your Calendars for March 31

Orphazyme (NASDAQ:ORPH) is falling after the drugmaker announced today that it would delist its...

InvestorPlace 22 Mar 2022

30 Stocks Moving in Tuesday's Pre-Market Session

Don’t forget to check out our premarket coverage here .

Benzinga 22 Mar 2022

Why Is Orphazyme (ORPH) Stock Up Today?

Orphazyme (NASDAQ:ORPH) stock is up more than 40% today on no news, raising speculation that inve...

InvestorPlace 17 Mar 2022

Why Is OXY Stock Up Today? Does Warren Buffett's Berkshire Want to Buy Occidental Petroleum?

Occidental Petroleum (NYSE:OXY) stock is rising higher on Thursday following news that Warren...

InvestorPlace 17 Mar 2022

22 Stocks Moving in Thursday's Pre-Market Session

TD Holdings, Inc. (NASDAQ: GLG) rose 81.2% to $0.43 in pre-market trading after the company repor...

Benzinga 17 Mar 2022

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.69% By Investing.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.69%

Investing.com 11 Mar 2022